Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic bronchitis; Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Acronyms REVASC
- 10 Jun 2017 Biomarkers information updated
- 23 Jun 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-005047-27).
- 23 Jun 2012 Company added in the association field, additional lead trial centre identified as reported by EudraCT.